行情

DBVT

DBVT

DBV Tech
NASDAQ

实时行情|Nasdaq Last Sale

3.950
-0.030
-0.75%
休市 16:00 03/27 EDT
开盘
3.980
昨收
3.980
最高
3.990
最低
3.870
成交量
13.31万
成交额
--
52周最高
13.49
52周最低
2.020
市值
3.71亿
市盈率(TTM)
-1.6980
分时
5日
1月
3月
1年
5年

分析师评级

9位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测DBVT价格均价为11.92,最高价位30.21,最低价为3.126。

EPS

DBVT 新闻

更多
  • 吉利德董事长:已向超千人提供瑞德西韦 几周内将有初步数据
  • 澎湃新闻 · 49分钟前
  • 大众CEO迪斯:每周损失20亿欧元 除中国市场外无收入
  • 21世纪经济报道 · 1小时前
  • 美国医用防护物资短缺 特朗普:波音、福特也要造呼吸机!
  • 环球网 · 1小时前
  • 朝“虑”夕改 特朗普称没必要对纽约等三州进行隔离
  • 央视 · 2小时前

所属板块

制药
-0.41%
制药与医学研究
-0.87%

热门股票

代码
价格
涨跌幅

DBVT 简况

DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.
展开

微牛提供DBV Technologies SA(NASDAQ-DBVT)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的DBVT股票新闻,以帮助您做出投资决策。